The dataset contains predictions of the incremental cost-effectiveness ratios (ICERs) for the rotavirus vaccine in 195 countries. Predictions are based on meta-regression estimates of ICERs on three sets of independent variables (true variation measured by country characteristics, intervention characteristics, and bias variables). Data used in the meta-regression analysis are 515 ICERs from 68 studies in the Tufts University’s cost-effectiveness analysis registries, and additional extractions of ICERs for sensitivity analyses.
Institute for Health Metrics and Evaluation (IHME). Rotavirus Vaccination Cost Effectiveness Estimates 2017. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2022.
Data made available for download on IHME Websites can be used, shared, modified or built upon by non-commercial users in accordance with the IHME FREE-OF-CHARGE NON-COMMERCIAL USER AGREEMENT. For more information (and inquiries about commercial use), visit IHME Terms and Conditions.